Medicare Review Questions Prostate Cancer Screenings

Tools

By Molly Clifton

A review of Medicare spending finds nearly 150 million dollars are spent each year on prostate cancer screenings for men 75 years and older, even though the tests have little benefit for men in that age group.

Many prostate cancers are slow-growing and unlikely to ever become harmful.

Researchers at Yale also found the costs vary widely according to region depending on how many follow-up procedures are ordered. 

The study concludes that many older men who are diagnosed with early stage prostate cancer may end up receiving therapy that could be harmful and costly.
 





This content requires the latest Adobe Flash Player and a browser with JavaScript enabled. Click here for a free download of the latest Adobe Flash Player.

Poll

Should Alabama Allow TV Cameras in Courtrooms?

  • Yes
  • No

What's onFull Schedule

Hot Video From AP

AP Video